Winfred
Back to Investors
LS

Laidlaw Scholars Ventures

Venture Capital

Laidlaw Scholars Ventures is a for-profit venture capital fund established by the Laidlaw Foundation to invest in start-ups founded by Laidlaw Scholars.

Portfolio

1

companies

Portfolio companies

CB

CardiaTec Biosciences

CardiaTec Biosciences applies artificial intelligence to multiomic data for cardiovascular drug discovery.

Team

NS

Niall Santamaria

Chief Investment Officer

Recent investments

Pre-Seed
£1.4M

CardiaTec Biosciences secures £1.4m pre-seed investment from Laidlaw Scholars Ventures and APEX Ventures

AI/MLBioTech

The pre-seed round was co-led by Laidlaw Scholars Ventures and APEX Ventures.

"Recent advances in artificial intelligence are generating novel ways to interpret multiomic data. I am excited to lead CardiaTec’s technology strategy to establish a new paradigm for understanding the pathophysiology of cardiovascular diseases."
— Namshik Han, CTO
CB
CardiaTec Biosciences— Cambridge, UK
LS
APEX Ventures
CG
Laidlaw Scholars Ventures + 4 others